SCHEMBL433065

SCHEMBL433065

CCCC=CCCCCC

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 4/20 0.62
TRPV1 Q8NER1 2/20 0.62
TERT O14746 3/20 0.52
CYP1A2 P05177 2/20 0.52
MAPT P10636 2/20 0.52
CYP2C19 P33261 2/20 0.52
BLM P54132 2/20 0.52
HSD17B10 Q99714 2/20 0.52
FABP4 P15090 2/20 0.52
PTPN1 P18031 2/20 0.52
PPARG P37231 2/20 0.52
KMT2A Q03164 2/20 0.52
PPARD Q03181 2/20 0.52
PPARA Q07869 2/20 0.52
GMNN O75496 1/20 0.52
USP2 O75604 1/20 0.52
LMNA P02545 1/20 0.52
POLB P06746 1/20 0.52
CYP2C9 P11712 1/20 0.52
ALOX15 P16050 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29274397 1.00 FAAH (0.62) FAAHTRPV1TERTCYP1A2MAPT
SCHEMBL15220019 1.00 FAAH (0.62) FAAHTRPV1TERTCYP1A2MAPT
SCHEMBL433064 1.00 FAAH (0.62) FAAHTRPV1TERTCYP1A2MAPT
SCHEMBL3378592 0.97 FAAH (0.67) FAAHTRPV1TERTCYP1A2MAPT
SCHEMBL5854970 0.97 FAAH (0.67) FAAHTRPV1TERTCYP1A2MAPT
SCHEMBL5853539 0.97 FAAH (0.67) FAAHTRPV1TERTCYP1A2MAPT
SCHEMBL454819 0.97 FAAH (0.67) FAAHTRPV1TERTCYP1A2MAPT
SCHEMBL5855886 0.97 FAAH (0.67) FAAHTRPV1TERTCYP1A2MAPT
SCHEMBL20584432 0.97 FAAH (0.67) FAAHTRPV1TERTCYP1A2MAPT
SCHEMBL5854348 0.97 FAAH (0.67) FAAHTRPV1TERTCYP1A2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 778 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122070352-A Sustainable aviation fuel produced from normal alpha olefin byproducts and method thereof 切弗朗菲利浦化学公司 2026-05-19 CN claimed
US-20260130860-A1 LIPIDS FOR DELIVERY OF THERAPEUTIC AGENTS FLAGSHIP LABS 114, INC. (US) 2026-05-14 US claimed
US-12618016-B2 Methods for producing aviation fuels CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2026-05-05 US claimed
US-20260103649-A1 SUSTAINABLE AVIATION FUEL FROM NORMAL ALPHA OLEFIN BYPRODUCTS AND PROCESS FOR SAME CHEVRON PHILLIPS CHEMICAL CO LP (US) 2026-04-16 US claimed
US-20260049256-A1 METHODS FOR PRODUCING AVIATION FUELS CHEVRON PHILLIPS CHEMICAL COMPANY LP 2026-02-19 US claimed
EP-4687854-A2 LIPIDS AND LIPID-LIKE COMPOUNDS FOR THERAPEUTIC LIPID NANOPARTICLE (LNP) DELIVERY Flagship Labs 114, Inc. (US) 2026-02-11 EP claimed
US-12540287-B2 Sustainable aviation fuel from normal alpha olefin byproducts and process for same CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2026-02-03 US claimed
EP-4577520-A1 PEGYLATED LIPID COMPOUNDS AND METHODS OF USE THEREOF Renagade Therapeutics Management Inc. (US) 2025-07-02 EP claimed
US-20250084331-A1 SUSTAINABLE AVIATION FUEL FROM NORMAL ALPHA OLEFIN BYPRODUCTS AND PROCESS FOR SAME CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2025-03-13 US claimed
WO-2025054258-A1 SUSTAINABLE AVIATION FUEL FROM NORMAL ALPHA OLEFIN BYPRODUCTS AND PROCESS FOR SAME CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2025-03-13 WO claimed
CN-116651513-A Catalyst for synthesizing linear high-carbon alcohol by hydroformylation reaction and preparation method thereof 中国科学院兰州化学物理研究所 2023-08-29 CN claimed
EP-3686221-B1 MIXED BRANCHED C20 SULFIDES COMPOSITIONS AND USE THEREOF AS CHAIN TRANSFER AGENTS CHEVRON PHILLIPS CHEMICAL CO LP (US) 2023-08-02 EP claimed
EP-4039668-A1 OLEFIN COMPOSITIONS Chevron Phillips Chemical Company LP (US) 2022-08-10 EP claimed
CN-113049696-B Metabolite for diagnosing whether subject suffers from Alzheimer disease and application thereof 首都医科大学宣武医院 2022-03-18 CN claimed
EP-2817145-B1 PRESSURE SENSITIVE ADHESIVE SHEET AND METHOD OF PRODUCING THEREOF DOW CHEMICAL TAIWAN LTD (TW) 2020-04-01 EP claimed
US-20030191306-A1 Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity G.D. SEARLE & CO. (US) 2003-10-09 US claimed
WO-1999013003-A1 BIODEGRADABLE POLYESTER COMPOSITIONS WITH NATURAL POLYMERS AND ARTICLES THEREOF BIOTECHNOLOGY RESEARCH AND DEVELOPMENT CORPORATION (US) 1999-03-18 WO claimed
EP-0128484-B1 PROCESS FOR PREPARING CARBOXYLIC ACID NEW JAPAN CHEMICAL CO.,LTD. (JP) 1988-01-20 EP claimed
US-4606863-A Process for preparing carboxylic acid NEW JAPAN CHEMICAL CO., LTD. (JP) 1986-08-19 US claimed
EP-0128484-A1 Process for preparing carboxylic acid NEW JAPAN CHEMICAL CO.,LTD. (JP) 1984-12-19 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12618016-B2 Methods for producing aviation fuels CYP4F8, CYP8B1, CYP2E1 FAAH 978/4885TRPV1 4329/4885TERT 1468/4885
US-20250084331-A1 SUSTAINABLE AVIATION FUEL FROM NORMAL ALPHA OLEFIN BYPRODUCTS AND PROCESS FOR SAME ECH1, YAP1, ECHS1 FAAH 828/4885TRPV1 3287/4885TERT 3214/4885
US-20030191306-A1 Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity CETP, DBI, MTTP FAAH 741/4885TRPV1 3853/4885TERT 1343/4885
US-20260103649-A1 SUSTAINABLE AVIATION FUEL FROM NORMAL ALPHA OLEFIN BYPRODUCTS AND PROCESS FOR SAME YAP1, CYP4F8, SCD FAAH 2017/4885TRPV1 3362/4885TERT 3837/4885
US-20260049256-A1 METHODS FOR PRODUCING AVIATION FUELS CYP4F8, CPT1A, CBR1 FAAH 1617/4885TRPV1 4405/4885TERT 2865/4885
US-12540287-B2 Sustainable aviation fuel from normal alpha olefin byproducts and process for same ADH1A, ADH1C, YAP1 FAAH 1482/4885TRPV1 4433/4885TERT 3524/4885
US-20260130860-A1 LIPIDS FOR DELIVERY OF THERAPEUTIC AGENTS NSUN3, NSUN2, LDLR FAAH 3270/4885TRPV1 3541/4885TERT 2186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.